Navigation Links
Prostate cancer recurrence attributed to obesity and rate of weight gain

Prostate cancer is one of the most common forms of cancer to be diagnosed in men. Several risk factors such as age, height, obesity, and genetic predisposition have been held responsible for the development of prostate cancer//.

A recent research conducted has offered insights into the association between obesity and prostate cancer. Men who gain weight rapidly between the ages of 25 and 40 are twice as likely to have recurrence of prostate cancer after surgery as men without rapid rates of weight gain.

Furthermore, patients who are obese at age 40 and at the time of time of diagnosis have a higher risk of recurrence. These patients are also more prone for biochemical failure, characterized by elevated PSA levels, following treatment. PSA, or prostate specific antigen, is a protein produced almost exclusively by the prostate. It is a screening marker, measured in blood, that when elevated to over four nanograms per milliliter is a signal for men and their clinicians to consider additional diagnostic tests. After removal of the prostate gland, however, the PSA level should be undetectable. Obese patients had elevated PSA levels much sooner after surgery – 12 months earlier – than their lighter counterparts.

The incorporation of body mass index at time of diagnosis with other measures of prostate cancer progression could enhance the predictive value of tools used to determine the risk each patient has for recurrence of prostate cancer.

Keeping this in mind, it would be beneficial if men only become more conscious about their weight and participate in weight reduction programs.

Page: 1

Related medicine news :

1. Cancer Doctors Okays Controversial Prostate Therapy
2. Radioactive Seeds used in Prostate Cancer treatment can migrate with the body
3. New Prostate Cancer Vaccine Shows Promise
4. Hormone Therapy applicable for Prostate Cancer
5. Prostate cancer and Vitamins
6. Response to chemotherapy could be measured by Prostate-Specific Antigen Doubling Time
7. Early Detection Of Prostate Cancer
8. Awareness increase Prostate cancer detection
9. Better Prostate Cancer Test
10. Stopping Prostate Cancer from Spreading
11. Drug might prevent Prostate Cancer Spread
Post Your Comments:

(Date:11/30/2015)... ... November 30, 2015 , ... It’s inevitable that everyone ... member, close friend, or animal pass away, death lives among us. It is your ... Coming from a family of 11 children, author T Sky understands that she may ...
(Date:11/30/2015)... ... November 30, 2015 , ... Sikka Software announced today that they are showcasing ... dentists to make complex business decisions by providing the tools and information they need ... survey with 10 procedures customized by zip code. , The Sikka Software Ecosystem ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... Novus’ TIGR® Matrix Surgical Mesh technology for soft tissue repair in the US ... is a long-term resorbable surgical mesh intended to support and reinforce soft tissue ...
(Date:11/30/2015)... , ... November 30, 2015 , ... ... be of critical importance to the medical schools of the future. To reach ... healthcare suite at the 2015 ChangeMedEd conference in Chicago, organized by the American ...
(Date:11/30/2015)... ... November 30, 2015 , ... ... a leading provider of enterprise Time and Attendance/Workforce Management cloud-based solutions, announced ... Microsoft Partner Program with competencies in the Application Development, demonstrating a “best-in-class” ...
Breaking Medicine News(10 mins):
(Date:11/30/2015)... 30, 2015 Varian Medical Systems (NYSE: VAR ) ... partnership with Apollo Hospitals Group, the largest hospital chain in ... train radiation technologists in the country. The MoU was signed by ... and Ashok Kakkar , Varian,s India ... India , Varian intends to deploy its Access to ...
(Date:11/30/2015)... and BOSTON , November ... research and develop potential new medicines directed at up ... therapeutic areas. --> PFE ) to research ... 10 G protein-coupled receptor (GPCR) targets across multiple therapeutic ... GPCR structure-guided drug discovery and development company and wholly-owned ...
(Date:11/29/2015)... Nov. 29, 2015  Strengthening its leadership in connected ... PHIA) today announced IntelliSpace Portal 8.0 , the ... visualization platform that helps radiologists detect, diagnose and follow-up ... Radiological Society of North America Annual Meeting (RSNA) ... 8.0 helps address the changing demands in radiology that ...
Breaking Medicine Technology: